rotation.to
Following this device: dark.
Free account
rotation.to
Sign in / Request free access
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Vinayak Doraiswamy

Chief Scientific Officer

Company insider

Files Form 4 as: Chief Scientific Officer, AtriCure.

Every Form 4 they filed

In numbers

Trades disclosed
36
Buys
0
Sells
7
Bought
$0
Sold
$2.1M
Companies
1
Companies where not an officer
0
First trade
30 Jun 2021
Last trade
28 Jul 2026
Last filed
30 Jul 2026

Companies traded

Where they are an officer
ATRC AtriCureOfficer · Medical Devices · last 28 Jul 20260 buys · 7 sells

Activity over time

1 Nov 2024 – 1 Oct 2026
10Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
28 Jul 2026filed 30 Jul 2026ATRC AtriCureMedical DevicesSEC FORM 4 Sold$233K6,000 at $38.88filing
28 Jul 2026filed 30 Jul 2026ATRC AtriCureMedical DevicesSEC FORM 4 Sold$233K6,000 at $38.88filing
30 Jun 2026filed 2 Jul 2026ATRC AtriCureMedical DevicesSEC FORM 4 Code A$15K636 at $23.78filing
30 Jun 2026filed 2 Jul 2026ATRC AtriCureMedical DevicesSEC FORM 4 Code A$15K636 at $23.78filing
15 May 2026filed 18 May 2026ATRC AtriCureMedical DevicesSEC FORM 4 Sold$141K5,000 at $28.13filing
15 May 2026filed 18 May 2026ATRC AtriCureMedical DevicesSEC FORM 4 Sold$141K5,000 at $28.13filing
12 Mar 2026filed 16 Mar 2026ATRC AtriCureMedical DevicesSEC FORM 4 Sold$149K5,000 at $29.83filing
12 Mar 2026filed 16 Mar 2026ATRC AtriCureMedical DevicesSEC FORM 4 Sold$149K5,000 at $29.83filing
1 Mar 2026filed 3 Mar 2026ATRC AtriCureMedical DevicesSEC FORM 4 Code A—30,390 at $0.00filing
1 Mar 2026filed 3 Mar 2026ATRC AtriCureMedical DevicesSEC FORM 4 Code A—15,198 at $0.00filing
1 Mar 2026filed 3 Mar 2026ATRC AtriCureMedical DevicesSEC FORM 4 Code F$487K15,585 at $31.26filing
1 Mar 2026filed 3 Mar 2026ATRC AtriCureMedical DevicesSEC FORM 4 Code A—30,390 at $0.00filing
1 Mar 2026filed 3 Mar 2026ATRC AtriCureMedical DevicesSEC FORM 4 Code A—15,198 at $0.00filing
1 Mar 2026filed 3 Mar 2026ATRC AtriCureMedical DevicesSEC FORM 4 Code F$487K15,585 at $31.26filing
5 Aug 2025filed 7 Aug 2025ATRC AtriCureMedical DevicesSEC FORM 4 Sold$91K2,500 at $36.58filing
30 Jun 2025filed 2 Jul 2025ATRC AtriCureMedical DevicesSEC FORM 4 Code A$21K822 at $25.84filing
28 May 2025filed 30 May 2025ATRC AtriCureMedical DevicesSEC FORM 4 Sold$84K2,500 at $33.44filing
1 Mar 2025filed 4 Mar 2025ATRC AtriCureMedical DevicesSEC FORM 4 Code A—19,359 at $0.00filing
1 Mar 2025filed 4 Mar 2025ATRC AtriCureMedical DevicesSEC FORM 4 Code A—6,579 at $0.00filing
1 Mar 2025filed 4 Mar 2025ATRC AtriCureMedical DevicesSEC FORM 4 Code F$375K9,672 at $38.74filing

News

Analyzing AxoGen (NASDAQ:AXGN) & AtriCure (NASDAQ:ATRC)ATRC · tickerreport.com · 18 Oct 2026

0 headlines in the last 90 days name Vinayak Doraiswamy; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.

Sectors

Health Care7

Buys in green, sells in red, by the company’s sector.

Related people

Salvatore PriviteraChief Technical Officer · Chief Technical Officer at AtriCure, filing Form 4 there in the last year
Regina E. GrovesDirector · Director at AtriCure, filing Form 4 there in the last year
Karl S. DahlquistChief Legal Officer · Chief Legal Officer at AtriCure, filing Form 4 there in the last year
Maggie YuenDirector · Director at AtriCure, filing Form 4 there in the last year
Karen PrangeDirector · Director at AtriCure, filing Form 4 there in the last year
Gilbert Ray Cisneros, Jr.Representative, CA-31 · Also traded ATRC in the last 90 days
Justin J. NozneskyChief Mktg & Strategy Officer · Also traded ATRC in the last 90 days
Sven WehrweinDirector · Also traded ATRC in the last 90 days